Life expectancy after an index hospitalization for patients with heart failure: A population-based study

被引:65
作者
Ko, Dennis T. [1 ,2 ]
Alter, David A. [1 ,3 ]
Austin, Peter C. [1 ]
You, John J. [1 ]
Lee, Douglas S. [1 ,4 ]
Qiu, Feng [1 ]
Stukel, Therese A. [1 ,5 ]
Tu, Jack V. [1 ,2 ,6 ]
机构
[1] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, Div Cardiol, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada
[3] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiol, Toronto, ON M5B 1W8, Canada
[4] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada
[5] Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA
[6] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON M4N 3M5, Canada
基金
加拿大健康研究院;
关键词
EJECTION FRACTION; ELDERLY-PATIENTS; MYOCARDIAL-INFARCTION; CLINICAL-MODEL; OLDER PATIENTS; MORTALITY; SURVIVAL; VALIDATION; PREDICTION; TRENDS;
D O I
10.1016/j.ahj.2007.08.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background An understanding of the life expectancy of patients with heart failure (HF) may assist in difficult treatment decisions such as placement of an implantable cardioverter-defibrillator or initiation of end-of-life care. However, previous studies have focused on predicting shorter-term mortality and limited data currently exist to predict expected survival among hospitalized patients with HF. Methods We studied 9943 patients who were newly hospitalized with HF between 1999 and 2001 in Ontario, Canada. Median survival was calculated using survival analysis and stratified by baseline characteristics and the EFFECT HF risk score. These analyses were repeated for the 1467 patients who had left ventricular ejection fraction of <= 30%. Results The average age of our HF cohort was 75.8 years and 50.4% of the patients were female. After a median follow-up of 6 years, hospitalized patients with HF had a 5-year mortality rate of 68.7% and a median survival of 2.4 years. Mortality varied substantially across risk groups such that median survival was only 8 months for patients in the high-risk group and only 3 months in the very high risk group. Similarly, among patients with depressed left ventricular ejection fraction, median survival was only 6 and 3 months in the high- and very high risk groups, respectively. Conclusions Prognostic estimations using median survival may improve the ability of physicians to identify subgroups of patients with HF who have limited life expectancy. This information may assist in communicating prognostic information and guiding difficult treatment decisions among hospitalized patients with HF.
引用
收藏
页码:324 / 331
页数:8
相关论文
共 38 条
  • [1] [Anonymous], 2004, QUALITY CARDIAC CARE
  • [2] [Anonymous], HEART DIS STROK STAT
  • [3] ARIAS E, 2006, NATL VITAL STAT REPO, V54, P10
  • [4] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Bardy, GH
    Lee, KL
    Mark, DB
    Poole, JE
    Packer, DL
    Boineau, R
    Domanski, M
    Troutman, C
    Anderson, J
    Johnson, G
    McNulty, SE
    Clapp-Channing, N
    Davidson-Ray, LD
    Fraulo, ES
    Fishbein, DP
    Luceri, RM
    Ip, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 225 - 237
  • [5] Outcome of heart failure with preserved ejection fraction in a population-based study
    Bhatia, R. Sacha
    Tu, Jack V.
    Lee, Douglas S.
    Austin, Peter C.
    Fang, Jiming
    Haouzi, Annick
    Gong, Yanyan
    Liu, Peter P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) : 260 - 269
  • [6] Using clinical guidelines designed for older adults with diabetes mellitus and complex health status
    Durso, SC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (16): : 1935 - 1940
  • [7] Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis
    Fonarow, GC
    Adams, KF
    Abraham, WT
    Yancy, CW
    Boscardin, WJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05): : 572 - 580
  • [8] Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease
    Fox, E
    Landrum-McNiff, K
    Zhong, ZS
    Dawson, NV
    Wu, AW
    Lynn, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17): : 1638 - 1645
  • [9] Understanding the treatment preferences of seriously ill patients
    Fried, TR
    Bradley, EH
    Towle, VR
    Allore, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (14) : 1061 - 1066
  • [10] Long-term survival after heart failure - A contemporary population-based perspective
    Goldberg, Robert J.
    Ciampa, Julia
    Lessard, Darleen
    Meyer, Theo E.
    Spencer, Frederick A.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (05) : 490 - 496